Literature DB >> 19340681

A case series of abuse of a new opioid combination, Norjizak.

Mansour Siavash1, Mohsen Janghorbani, Farzad Gheshlaghi, Seyed Hasan Adeli, Mohsen Saljoughi, Farhad Moradi, Maede Majidinezhad.   

Abstract

Cushing's syndrome results from lengthy and inappropriate exposure to excessive concentrations of either endogenous or exogenous glucocorticoids. This study described 30 patients with a novel type of severe exogenous Cushing's syndrome in a group of intravenous drug users due to illicit use and dependence on a new opioid combination, Norjizak. Thirty consecutive patients (2 women and 28 men) who presented with a novel type of severe exogenous Cushing's syndrome and other complications were admitted to the emergency departments of Qom and Isfahan University of Medical Sciences, Isfahan, Iran, between September 2005 and September 2007 were enrolled. All participating patients were intravenous drug users who used a narcotic drug called Norjizak, a combination of different opioids with dexamethason or benzodiazepines. Patients were first evaluated and managed based on the current illness, and then entered into a detoxification program by a medical team. Clinical data were collected by an open interview and the patient's files using a standard form. High-performance liquid chromatography was used to determined glucocorticoid existence in the brand. The major complaints and clinical findings were withdrawal symptoms, severe edema, osteoporotic fracture, impairment in glucose tolerance, decreased libido, and sepsis (including necrotizing pneumonia, cutaneous infection, multivalvular endocarditis, osteomyelitis, and urogenital infection). Most patients had started with 2 or 3 vials per day and then increased the dose compulsively to maximum of approximately 15 to 20 vials per day. The concentration of Dexamethhasone disodium phosphate in each 2 mL vial was 0.4 to 1 mg/mL. Heroin was also found in them. We are witnessing a special exogenous Cushing syndrome due to the mixing of opiates and dexamethasone. Norjizak syndrome is the clinical condition of poisoning with a second material when it is combined with opiates due to compulsive dose increment and long duration.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19340681     DOI: 10.1080/10550880902772928

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  4 in total

Review 1.  The effects of opioids on the lung.

Authors:  Joshua B Radke; Kelly P Owen; Mark E Sutter; Jonathan B Ford; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

2.  Norjizak injection: a critical risk for transmitting blood-borne infectious diseases.

Authors:  Zahra Alam Mehrjerdi
Journal:  Hepat Mon       Date:  2013-04-06       Impact factor: 0.660

3.  Patterns of pre-treatment drug abuse, drug treatment history and characteristics of addicts in methadone maintenance treatment in Iran.

Authors:  Hajar Shekarchizadeh; Hamed Ekhtiari; Mohammad R Khami; Jorma I Virtanen
Journal:  Harm Reduct J       Date:  2012-06-07

4.  Comparison of total hip arthroplasty and core decompression in avascular necrosis of the femoral head after taking temgesic and norgesic.

Authors:  Mahmood Karimi-Mobarake; Ali Nemati; Ali Kheradmand; Ghodratollah Rajabyzadeh
Journal:  Addict Health       Date:  2012 Summer-Autumn
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.